Secretory IgA anti-HAV in saliva of hepatitis A patients
スポンサーリンク
概要
著者
-
SATA Michio
Second Department of Internal Medicine, Kurume University
-
SUZUKI Hiroshi
Second Department of Medicine, Kurume University School of Medicine
-
Sata Michio
Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine
-
SETOYAMA Hiroshi
Second Department of Medicine, Kurume University School of Medicine
-
TANIKAWA Kynichi
Second Department of Medicine, Kurume University School of Medicine
-
Tanikawa Kynichi
Second Department Of Medicine Kurume University School Of Medicine
-
Setoyama Hiroshi
Second Department Of Medicine Kurume University School Of Medicine
関連論文
- Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
- Human primary cultured hepatic stellate cells can be cryopreserved
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
- Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
- Periostin and bone marrow fibrosis
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Keratin inclusions alter cytosolic protein localization in hepatocytes
- Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
- A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
- A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
- Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
- Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
- Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
- Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
- Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
- Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets
- High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
- Systemic Sclerosis Associated with Diabetes Insipidus
- Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
- Immunoregulatory cytokines and intestinal inflammation
- Intestinal microflora as a therapeutic target in inflammatory bowel disease
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
- Cytomegalovirus Pneumonitis Presenting Small Nodular Opacities
- Propranolol ameliorates thrombocytopenia in patients with cirrhosis
- Upright posture blunts postprandial splanchnic hyperemia in patients with cirrhosis and portal hypertension
- Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment
- Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC
- GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC).
- Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
- Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif)
- Erythropoietic protoporphyria with fatal liver failure
- Intracellular traffic of asialoglycoproteins depends on vacuolar pH in polarized isolated rat hepatocyte couplets
- Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
- In Vitro Study of Neutrophil Apoptosis in Liver Cirrhosis
- Involvement of GBV-C/HGV in liver diseases in Japan
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
- Clinical Significance of the DNA Index in Hematogenous Dissemination of Aneuploid Colorectal Cancer
- Prognostic Significance of the Bromodeoxyuridine Labeling Index in Primary Colorectal Carcinoma
- Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
- Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
- Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
- Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
- Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
- Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
- Long-term improvement of hepatic fibrosis in chronic hepatitis C treated with interferon-α
- Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
- Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis
- Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
- Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection
- A pilot study of natural interferon γ therapy for chronic hepatitis C
- Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
- Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels:A Comparison with Symptomatic Carriers
- High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection
- Natural disappearance of serum HCV RNA: prospective study in a hyperendemic area
- Association of HLA-DRB1 0803 and 1602 with the susceptibility to primary biliary cirrhosis
- Secretory IgA anti-HAV in bile of hepatitis A patients
- Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
- Secretory IgA anti-HAV in saliva of hepatitis A patients
- Decreased regional cerebral blood flow during interferon therapy
- Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
- Immunological evaluation in oral lichen planus with chronic hepatitis C
- Multiple primary neoplasms and hepatitis C virus infection in oral cancer patients
- Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
- Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
- Atypical Manifestations of Pancreatitis with Autoimmune Phenomenon in an Adolescent Female
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
- Reninlike Activity in Kidneys of Rats with Various Types of Experimental Hypertension
- The Role of Neural Factors in Experimental Renal Hypertension
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Effects of DNA Ploidy Patterns on the Survival of Patients with Primary Gastrointestinal Lymphoma
- Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
- Electrochemotherapy Significantly Inhibits the Growth of Colon 26 Tumors in Mice
- Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy